Pacer Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $314K | Sell |
5,713
-623
| -10% | -$34.2K | ﹤0.01% | 1569 |
|
|
2025
Q1 | $448K | Sell |
6,336
-31,087
| -83% | -$2.2M | ﹤0.01% | 1481 |
|
|
2024
Q4 | $2.46M | Buy |
37,423
+1,938
| +5% | +$127K | 0.01% | 874 |
|
|
2024
Q3 | $2.49M | Sell |
35,485
-1,847
| -5% | -$130K | 0.01% | 862 |
|
|
2024
Q2 | $3.07M | Buy |
37,332
+36,829
| +7,322% | +$3.03M | 0.01% | 750 |
|
|
2024
Q1 | $43.9K | Buy |
+503
| New | +$43.9K | ﹤0.01% | 3219 |
|
|
2021
Q2 | – | Sell |
-1,019
| Closed | -$77K | – | 1428 |
|
|
2021
Q1 | $77K | Sell |
1,019
-646
| -39% | -$48.8K | ﹤0.01% | 1330 |
|
|
2020
Q4 | $146K | Sell |
1,665
-11,832
| -88% | -$1.04M | ﹤0.01% | 1287 |
|
|
2020
Q3 | $1.03M | Sell |
13,497
-709
| -5% | -$53.9K | 0.02% | 692 |
|
|
2020
Q2 | $1.75M | Sell |
14,206
-370
| -3% | -$45.6K | 0.04% | 411 |
|
|
2020
Q1 | $1.3M | Buy |
14,576
+1,208
| +9% | +$108K | 0.03% | 212 |
|
|
2019
Q4 | $1.13M | Buy |
13,368
+1,453
| +12% | +$123K | 0.05% | 512 |
|
|
2019
Q3 | $803K | Buy |
11,915
+814
| +7% | +$54.9K | 0.02% | 887 |
|
|
2019
Q2 | $951K | Buy |
11,101
+1,127
| +11% | +$96.5K | 0.02% | 823 |
|
|
2019
Q1 | $886K | Buy |
+9,974
| New | +$886K | 0.02% | 483 |
|
|
2018
Q4 | – | Sell |
-9,180
| Closed | -$890K | – | 594 |
|
|
2018
Q3 | $890K | Buy |
9,180
+3,528
| +62% | +$342K | 0.03% | 690 |
|
|
2018
Q2 | $532K | Buy |
5,652
+1,048
| +23% | +$98.6K | 0.02% | 891 |
|
|
2018
Q1 | $373K | Sell |
4,604
-44
| -0.9% | -$3.57K | 0.02% | 826 |
|
|
2017
Q4 | $414K | Sell |
4,648
-1,418
| -23% | -$126K | 0.03% | 767 |
|
|
2017
Q3 | $565K | Buy |
6,066
+744
| +14% | +$69.3K | 0.05% | 605 |
|
|
2017
Q2 | $483K | Buy |
5,322
+687
| +15% | +$62.3K | 0.05% | 622 |
|
|
2017
Q1 | $407K | Buy |
4,635
+193
| +4% | +$16.9K | 0.05% | 610 |
|
|
2016
Q4 | $368K | Sell |
4,442
-86
| -2% | -$7.13K | 0.05% | 564 |
|
|
2016
Q3 | $419K | Buy |
4,528
+189
| +4% | +$17.5K | 0.06% | 441 |
|
|
2016
Q2 | $338K | Buy |
4,339
+52
| +1% | +$4.05K | 0.05% | 512 |
|
|
2016
Q1 | $353K | Buy |
4,287
+109
| +3% | +$8.98K | 0.08% | 261 |
|
|
2015
Q4 | $437K | Buy |
+4,178
| New | +$437K | 0.1% | 201 |
|